Authored 10 patents, 15-years R&D experience with emphasis on small, portable instrumentation. 6 successful startups, including the first acoustic cytometer (sold to Invitrogen) and a disposable molecular diagnostic for point-of-care. Designed and developed products spanning fields of electrochemistry, catalysis, smart materials, acoustics, robotics, micro-fluidics, and diagnostics. MS in Electroanalytical Chemistry and BS in Biology + Chemistry.

Experienced research technologist and molecular biologist, with expertise in PCR assay development, prototyping of nucleic acid isolation devices, qRT-PCR assay development, and lyophilization development. Started Nucleic Acid Isolation and Quantitative Real-Time PCR Core Laboratory at Lovelace Respiratory Research Institute Experience in developing country settings, particularly Central America. BS in Biology.

Founded 3 successful start-ups, including ReMail next generation mobile email sold to Google. CEO of Left Coast R&D, boutique mobile strategy and development firm specializing in rapid prototyping of iOS and Android apps. 2 years as visiting professor at Cornell University, focused on mobile distributed file systems and reliability in high performance/high latency networks. BSc, MSc, and PhD in Computer Science.

15 years business experience, including 10 years international business strategy consulting, as well as eCommerce and enterprise management systems development and project management. BA from Cornell University and an MBA and MAIEP from the Monterey Institute of International Studies.

Chairman and CEO of Marinus Pharmaceuticals, Inc and Executive Chairman of Rapid Micro Biosystems. Prior to Marinus Chris co-founded Protez Pharmaceuticals and served as Director, President and CEO. Protez was acquired by Novartis in 2008. Chris also serves on the board of directors of Noble Biomaterials, MBF Therapeutics, Mid-Atlantic Diamond Ventures and the Science Center.

Co-founder of Lyfix Labs focused on developing personal healthcare management solutions. Experienced in iOS, Ruby on Rails, HTML5, C++, and Parse.

Founding Partner of Quaker Partners venture capital firm. Previously: President of S.R. One, GlaxoSmithKline’s venture capitol arm, and General Partner of EuclidSR Partners, an independent venture capitol fund focused on healthcare and information technology.

Professor of Clinical Medicine and Instructor in Internal Medicine at the University of Pennsylvania Perelman School of Medicine. Co-Principle Investigator in Phase 2 study of 1a or 1b HCV infection. Previously director of business development for Maxigen as well as Valentis, and MIT’s office of technology licensing.